Motco Gilead Sciences, Inc. Transaction History

Motco

$991 Million
Q3 2024

A detailed history of Motco transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Motco holds 45 shares of GILD stock, worth $4,011. This represents 0.0% of its overall portfolio holdings.

Number of Shares

Previous 45 -0.0%

Holding current value

$4,011

Previous $3,000 -0.0%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 09, 2024	SELL	$71.58 - $87.29 $214 - $261	-3 Reduced 6.25%	45 $3,000
Q3 2023 Nov 07, 2023	SELL	$73.94 - $80.67 $1,404 - $1,532	-19 Reduced 28.36%	48 $3,000
Q2 2023 Aug 04, 2023	SELL	$76.01 - $86.7 $19,686 - $22,455	-259 Reduced 79.45%	67 $5,000
Q1 2023 May 09, 2023	SELL	$77.31 - $88.08 $10,823 - $12,331	-140 Reduced 30.04%	326 $27,000
Q4 2022 Feb 10, 2023	BUY	$62.32 - $89.47 $26,236 - $37,666	421 Added 935.56%	466 $40,000
Q3 2022 Nov 03, 2022	SELL	$59.54 - $68.01 $10,479 - $11,969	-176 Reduced 79.64%	45 $3,000
Q1 2022 May 06, 2022	BUY	$57.92 - $72.58 $12,800 - $16,040	221 New	221 $13,000
Q1 2021 Apr 16, 2021	SELL	$60.0 - $68.46 $2,700 - $3,080	-45 Closed	0 $0
Q4 2020 Feb 05, 2021	SELL	$56.65 - $64.55 $12,463 - $14,201	-220 Reduced 83.02%	45 $3,000
Q1 2020 May 06, 2020	BUY	$62.63 - $80.22 $1,189 - $1,524	19 Added 7.72%	265 $20,000
Q4 2019 Feb 06, 2020	BUY	$61.62 - $67.78 $1,602 - $1,762	26 Added 11.82%	246 $16,000
Q3 2019 Nov 05, 2019	SELL	$62.51 - $69.0 $29,379 - $32,430	-470 Reduced 68.12%	220 $14,000
Q2 2019 Aug 07, 2019	BUY	$61.87 - $69.38 $29,078 - $32,608	470 Added 213.64%	690 $47,000
Q1 2019 May 02, 2019	SELL	$62.53 - $70.05 $13,381 - $14,990	-214 Reduced 49.31%	220 $14,000
Q4 2018 Feb 08, 2019	SELL	$60.54 - $79.0 $1,755 - $2,291	-29 Reduced 6.26%	434 $27,000
Q1 2018 May 08, 2018	SELL	$72.84 - $88.8 $2,258 - $2,752	-31 Reduced 6.28%	463 $35,000
Q2 2017 Aug 08, 2017	BUY	N/A	494	494 $35,000

Others Institutions Holding GILD

# of Institutions

1,930

Shares Held

992M

Call Options Held

10.5M

Put Options Held

9.75M

Black Rock Inc. New York, NY

121M
Shares

$10.8 Billion
0.19% of portfolio
Vanguard Group Inc Valley Forge, PA

115M
Shares

$10.3 Billion
0.18% of portfolio
Capital World Investors Los Angeles, CA

76.5M
Shares

$6.82 Billion
1.03% of portfolio
Capital Research Global Investors Los Angeles, CA

61.8M
Shares

$5.51 Billion
1.12% of portfolio
State Street Corp Boston, MA

60.2M
Shares

$5.36 Billion
0.21% of portfolio

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $112B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Motco, based on Form 13F filings with the SEC.

News

Stay updated on Motco with notifications on news.

Account